Seaweed drug brings hope to the obese
By Express News Service | Published: 18th February 2017 10:25 PM |
KOCHI: The Central Marine Fisheries Research Institute (CMFRI) here has developed an anti-obesity nutraceutical from seaweeds.
Cadalmin (TM) Anti-hypercholesterolemic extract (CadalminTM ACe) is a natural remedy for obesity and dyslipidemia. Kerala Governor P Sathasivam will launched it at the inauguration of the CMFRI Platinum Jubilee here on Saturday.
CMFRI scientists produced the extract from seaweeds available in the country’s seas.
Dr Kajal Chakraborty, senior scientist in the Marine Biotechnology Division who developed the product, said bioactive pharmacophore leads from seaweeds were used to prepare the nutraceutical product.
“CadalminTM Antihypercholesterolemic extract can be administered to regulate clinical indicators leading to dyslipidemia or obesity, total adipose tissue and visceral fat, triglycerides and good and bad cholesterol. It contains 100 per cent natural marine bioactive ingredients from selected seaweeds and will would be available in 400 mg capsules,” he said.
Dr P Vijayagopal, Head, Marine Biotechnology Division, said the active ingredients in the product will be packed in capsules to meet the dietary needs of the large vegetarian population in India and abroad.
“CadalminTM Antihypercholesterolemic extract has a promising consumer appeal and market potential especially for the sizeable vegetarian population in India and abroad,” he said.